Allergy Therapeutics's total assets for Q4 2022 were £73.58M, a decrease of -20.00% from the previous quarter. GB:AGY total liabilities were £35.18M for the fiscal quarter, a -4.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.